Matches in Wikidata for { <http://www.wikidata.org/entity/Q91438582> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- Q91438582 description "2019 թվականի փետրվարի 10-ին հրատարակված գիտական հոդված" @default.
- Q91438582 description "article scientifique publié en 2019" @default.
- Q91438582 description "artículu científicu espublizáu en febreru de 2019" @default.
- Q91438582 description "scientific article published on 10 February 2019" @default.
- Q91438582 description "wetenschappelijk artikel" @default.
- Q91438582 description "наукова стаття, опублікована 10 лютого 2019" @default.
- Q91438582 name "Ibrutinib provides favourable survival outcomes in patients with comorbidities versus established therapies" @default.
- Q91438582 name "Ibrutinib provides favourable survival outcomes in patients with comorbidities versus established therapies" @default.
- Q91438582 type Item @default.
- Q91438582 label "Ibrutinib provides favourable survival outcomes in patients with comorbidities versus established therapies" @default.
- Q91438582 label "Ibrutinib provides favourable survival outcomes in patients with comorbidities versus established therapies" @default.
- Q91438582 prefLabel "Ibrutinib provides favourable survival outcomes in patients with comorbidities versus established therapies" @default.
- Q91438582 prefLabel "Ibrutinib provides favourable survival outcomes in patients with comorbidities versus established therapies" @default.
- Q91438582 P1433 Q91438582-1EA0E853-916E-4AD9-A299-D2707C2EDB3C @default.
- Q91438582 P1476 Q91438582-84FDEFFD-FF5F-4C64-B390-C23A184EB6AB @default.
- Q91438582 P2093 Q91438582-26AA20E2-B154-433F-952A-4774E0B3946C @default.
- Q91438582 P2093 Q91438582-30CD2B91-E046-4564-94C2-556E13FCC2CA @default.
- Q91438582 P2093 Q91438582-4B47EF49-BF95-4495-BAA2-F4BB3C74B0F2 @default.
- Q91438582 P2093 Q91438582-635DA302-A933-45BD-8892-DE6CC1CC8F4F @default.
- Q91438582 P2093 Q91438582-905BD836-3CD6-48EA-A747-5FF79A18DCEF @default.
- Q91438582 P2093 Q91438582-A1141EB6-2AE4-4A27-A0AE-B5A448B08CFE @default.
- Q91438582 P2093 Q91438582-A562F9BA-0171-4FB0-9376-D14FB53F9A35 @default.
- Q91438582 P2093 Q91438582-A6F9E698-72E2-4936-9D12-AE4F1B93ED49 @default.
- Q91438582 P2093 Q91438582-D5A88FFF-9A58-4254-8616-765EE2499380 @default.
- Q91438582 P304 Q91438582-668DB360-6D1B-4CD6-AE26-1E6B36306A7D @default.
- Q91438582 P31 Q91438582-642ABD94-1BB6-44F3-AC38-7142FEF77E5D @default.
- Q91438582 P356 Q91438582-58943026-0E6D-432C-BC55-C6567FB6A226 @default.
- Q91438582 P433 Q91438582-CB618E33-F571-43AB-87D0-6A5A12B56000 @default.
- Q91438582 P478 Q91438582-4C58B585-2D79-428B-9AF7-8503A2DA6090 @default.
- Q91438582 P50 Q91438582-51C6A6EF-8384-4406-B963-179852C67E7C @default.
- Q91438582 P577 Q91438582-3CB3D3F8-C0E4-496D-9820-6F506A2737D5 @default.
- Q91438582 P698 Q91438582-0E41645E-2FC3-4211-B8D3-06F7C60AA3AB @default.
- Q91438582 P921 Q91438582-9EAC0D19-D873-432B-9D43-30FD58E31A89 @default.
- Q91438582 P921 Q91438582-FDCA1E40-6809-4E55-B9B1-A8BF0B14FCEB @default.
- Q91438582 P356 BJH.15784 @default.
- Q91438582 P698 30739324 @default.
- Q91438582 P1433 Q4970200 @default.
- Q91438582 P1476 "Ibrutinib provides favourable survival outcomes in patients with comorbidities versus established therapies" @default.
- Q91438582 P2093 "Alessandra Tedeschi" @default.
- Q91438582 P2093 "Anthony Mato" @default.
- Q91438582 P2093 "John C Byrd" @default.
- Q91438582 P2093 "Marie-Sarah Dilhuydy" @default.
- Q91438582 P2093 "Paul M Barr" @default.
- Q91438582 P2093 "Paula Cramer" @default.
- Q91438582 P2093 "Stephen Chang" @default.
- Q91438582 P2093 "Thorsten Graef" @default.
- Q91438582 P2093 "Tony Lin" @default.
- Q91438582 P304 "175-180" @default.
- Q91438582 P31 Q13442814 @default.
- Q91438582 P356 "10.1111/BJH.15784" @default.
- Q91438582 P433 "1" @default.
- Q91438582 P478 "186" @default.
- Q91438582 P50 Q87038533 @default.
- Q91438582 P577 "2019-02-10T00:00:00Z" @default.
- Q91438582 P698 "30739324" @default.
- Q91438582 P921 Q1414874 @default.
- Q91438582 P921 Q5984881 @default.